These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14689240)

  • 1. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.
    Castelli C; Rivoltini L; Rini F; Belli F; Testori A; Maio M; Mazzaferro V; Coppa J; Srivastava PK; Parmiani G
    Cancer Immunol Immunother; 2004 Mar; 53(3):227-33. PubMed ID: 14689240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
    Strbo N; Podack ER
    Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
    Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
    Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines.
    Li Z
    Semin Immunol; 1997 Oct; 9(5):315-22. PubMed ID: 9327526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell stress proteins: novel immunotherapeutics.
    Calderwood SK; Gong J; Theriault JR; Mambula SS; Gray PJ
    Novartis Found Symp; 2008; 291():115-31; discussion 131-40. PubMed ID: 18575270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells.
    Binder RJ; Harris ML; Ménoret A; Srivastava PK
    J Immunol; 2000 Sep; 165(5):2582-7. PubMed ID: 10946285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock proteins (HSPs) based anti-cancer vaccines.
    Ciocca DR; Cayado-Gutierrez N; Maccioni M; Cuello-Carrion FD
    Curr Mol Med; 2012 Nov; 12(9):1183-97. PubMed ID: 22804241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of multiple heat shock proteins from a single tumor sample.
    Ménoret A; Bell G
    J Immunol Methods; 2000 Apr; 237(1-2):119-30. PubMed ID: 10725457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.
    Guo C; Subjeck JR; Wang XY
    Methods Mol Biol; 2018; 1709():345-357. PubMed ID: 29177671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing antigen cross-presentation and T-cell priming by complexing protein antigen to recombinant large heat-shock protein.
    Wang XY; Yi H; Yu X; Zuo D; Subjeck JR
    Methods Mol Biol; 2011; 787():277-87. PubMed ID: 21898243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of chaperone-antigen peptide vaccine derived from human gastric cancer stem cells and its immune function].
    Jiang YQ; Guo QM; Xu XP; Liang JC; He YY; An SH; Su F; Li CY; Huang CX
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):109-114. PubMed ID: 28219205
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat-shock protein-peptide complex-96 for the treatment of cancer.
    Amato RJ
    Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.
    Heike M; Weinmann A; Bethke K; Galle PR
    Biochem Pharmacol; 1999 Nov; 58(9):1381-7. PubMed ID: 10513981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
    Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
    J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.